Table 2.
Achievement rates of target intact PTH, corrected calcium, and phosphorus levels during the evaluation period (week 28 to week 30) by prior cinacalcet use
| Prior cinacalcet use |
||
|---|---|---|
| Nonusers |
Users |
|
| n = 98 | n = 155 | |
| Intact PTH | ||
| n (%) | 80 (81.6) | 104 (67.1) |
| Difference (95% CI) | –14.5 (–24.59, –3.34) | |
| Corrected calcium | ||
| n (%) | 67 (68.4) | 104 (67.1) |
| Difference (95% CI) | –1.3 (–12.66, 10.68) | |
| Phosphate | ||
| n (%) | 67 (68.4) | 108 (69.7) |
| Difference (95% CI) | 1.3 (–10.02, 13.13) | |
| Intact PTH, corrected calcium and phosphate | ||
| n (%) | 41 (41.8) | 58 (37.4) |
| Difference (95% CI) | –4.4 (–16.67, 7.73) | |
CI, confidence interval; PTH, parathyroid hormone.